[go: up one dir, main page]

ES8602665A1 - Un procedimiento para la obtencion de medicamentos a base dederivados de la 1,4-dihidropiridina - Google Patents

Un procedimiento para la obtencion de medicamentos a base dederivados de la 1,4-dihidropiridina

Info

Publication number
ES8602665A1
ES8602665A1 ES540811A ES540811A ES8602665A1 ES 8602665 A1 ES8602665 A1 ES 8602665A1 ES 540811 A ES540811 A ES 540811A ES 540811 A ES540811 A ES 540811A ES 8602665 A1 ES8602665 A1 ES 8602665A1
Authority
ES
Spain
Prior art keywords
alkyl
alkoxy
halogen
amino
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES540811A
Other languages
English (en)
Other versions
ES540811A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8602665A1 publication Critical patent/ES8602665A1/es
Publication of ES540811A0 publication Critical patent/ES540811A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN PROCEDIMIENTO PARA LA OBTENCION DE MEDICAMENTOS A BASE DE DERIVADOS DE LA 1,4, -DIHIDROPIRIDINA DE FORMULA (I).CONSISTE EN: A) HACER REACCIONAR DIHIDROPIRIDINAS DE FORMULA (VI) CON UNA AMINA O SE TRANSFORMA EN UN DERIVADO REACTIVO DE ACIDO, COMO UN ESTER ACTIVADO, ESTER DE HIDROXISUCCINIMIDA O IMIDAZOLIDOS DE ACIDO Y ESTE SE HACE REACCIONAR CON AMINAS DE FORMULA (VII), EN DISOLVENTE ORGANICO INERTE Y A TEMPERATURA ENTRE 20 Y 150 C PARA OBTENER EL PRODUCTO (I) DONDE R1 Y R2 PUEDEN SER IGUALES O DIFERENTES Y SIGNIFICAN HIDROGENO O ALQUILO C1-C4 U OTROS VARIOS RADICALES, R2 Y R3 SON IGUALES O DIFERENTES Y SIGNIFICAN HIDROGENO O RESTO ALQUILO C1-C4 U OTROS VARIOS RADICALES.
ES540811A 1983-06-01 1985-02-28 Un procedimiento para la obtencion de medicamentos a base dederivados de la 1,4-dihidropiridina Granted ES540811A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833319956 DE3319956A1 (de) 1983-06-01 1983-06-01 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES8602665A1 true ES8602665A1 (es) 1985-12-01
ES540811A0 ES540811A0 (es) 1985-12-01

Family

ID=6200484

Family Applications (3)

Application Number Title Priority Date Filing Date
ES532791A Expired ES8506626A1 (es) 1983-06-01 1984-05-24 Derivados de la 1, 4-dihidropiridina
ES540810A Granted ES540810A0 (es) 1983-06-01 1985-02-28 Un procedimiento para la obtencion de medicamentos a base de derivados de la 1,4-dihidropiridina.
ES540811A Granted ES540811A0 (es) 1983-06-01 1985-02-28 Un procedimiento para la obtencion de medicamentos a base dederivados de la 1,4-dihidropiridina

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES532791A Expired ES8506626A1 (es) 1983-06-01 1984-05-24 Derivados de la 1, 4-dihidropiridina
ES540810A Granted ES540810A0 (es) 1983-06-01 1985-02-28 Un procedimiento para la obtencion de medicamentos a base de derivados de la 1,4-dihidropiridina.

Country Status (13)

Country Link
US (1) US4540684A (es)
EP (1) EP0127826B1 (es)
JP (1) JPS59227860A (es)
KR (1) KR850000397A (es)
AT (1) ATE54309T1 (es)
AU (1) AU569298B2 (es)
CA (1) CA1242706A (es)
DE (2) DE3319956A1 (es)
DK (1) DK269784A (es)
ES (3) ES8506626A1 (es)
HU (1) HU191665B (es)
IL (1) IL71950A (es)
ZA (1) ZA844118B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315805A1 (de) 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
DE3348281C2 (en) * 1983-04-30 1989-06-15 Bayer Ag, 5090 Leverkusen, De Microemulsion of non lipoid surfactant and partly miscible solvent
EP0145956A1 (de) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Neue Amid-Verbindungen
DE3420784A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 3-nitro-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3445852A1 (de) * 1984-12-15 1986-06-19 Bayer Ag, 5090 Leverkusen Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPS62174050A (ja) * 1985-10-21 1987-07-30 Nippon Shoji Kk 3−アミノカルボニル−1,4−ジヒドロピリジン−5−カルボン酸誘導体、その製法および医薬組成物
US5064580A (en) * 1988-03-31 1991-11-12 The Dow Chemical Company Process for making microporous membranes from poly(etheretherketone)-type polymers
US5227101A (en) * 1988-03-31 1993-07-13 The Dow Chemical Company Process of making microporous membranes from poly(etheretherketone)-type polymers and low melting point crystallizable polymers
US5205968A (en) * 1988-03-31 1993-04-27 The Dow Chemical Company Process for making a microporous membrane from a blend containing a poly(etheretherketone)-type polymer, an amorphous polymer, and a solvent
US4904426A (en) * 1988-03-31 1990-02-27 The Dow Chemical Company Process for the production of fibers from poly(etheretherketone)-type polymers
CA2069877A1 (en) * 1990-10-02 1992-04-03 Michio Nakanishi Ethynylphenyl derivative substituted by pyridazinone and medicament for circulatory disease containing the same as an effective ingredient
EP1191022A4 (en) * 1999-06-23 2002-09-18 Ajinomoto Kk NEW DIHYDROPYRIDINE DERIVATIVES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2228377A1 (de) * 1972-06-10 1974-01-03 Bayer Ag Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln

Also Published As

Publication number Publication date
AU569298B2 (en) 1988-01-28
DK269784D0 (da) 1984-05-30
IL71950A0 (en) 1984-09-30
KR850000397A (ko) 1985-02-27
IL71950A (en) 1987-10-20
EP0127826A3 (en) 1987-07-29
US4540684A (en) 1985-09-10
ES532791A0 (es) 1985-07-16
ZA844118B (en) 1985-02-27
ATE54309T1 (de) 1990-07-15
JPS59227860A (ja) 1984-12-21
DE3319956A1 (de) 1984-12-06
EP0127826B1 (de) 1990-07-04
HUT34447A (en) 1985-03-28
DE3482626D1 (de) 1990-08-09
ES8602660A1 (es) 1985-12-01
ES540811A0 (es) 1985-12-01
HU191665B (en) 1987-03-30
EP0127826A2 (de) 1984-12-12
ES8506626A1 (es) 1985-07-16
CA1242706A (en) 1988-10-04
ES540810A0 (es) 1985-12-01
AU2870984A (en) 1984-12-06
DK269784A (da) 1984-12-02

Similar Documents

Publication Publication Date Title
ES8602665A1 (es) Un procedimiento para la obtencion de medicamentos a base dederivados de la 1,4-dihidropiridina
NO2017067I2 (no) Everolimus - forlenget SPC
ES8604516A1 (es) Un derivado de dihidropiridina
IL111290A (en) Uses of 2-phenyl-3-aroylbenzothiophenes in the preparation of medicaments useful in the treatment of peri-menopausal syndrome
FI934298A0 (fi) Kristallin tiagabine-hydrokloridmonohydrat, dess framstaellning och dess anvaendning
ZA919030B (en) Compounds of n-benzoyl proline,process for their preparation and pharmaceutical compositions containing them
HUT66515A (en) Process for preparing piperidine derivatives and pharmaceutical compositions contg. them as active ingredients
PT78854B (fr) Procede de preparation de derives 7-(pyrrol-1-yl)des acides 1-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxiliques et 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxiliques substitues et de compositions pharmaceutiques les contenant
YU50590A (sh) Supstituisani derivati azetidinil piridon karbonskih kiselina i postupak za njihovu izradu
DE3869144D1 (de) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
DE3868013D1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE189806T1 (de) Substituierte benzylderivate von polyalkylenpolyaminen und ihre verwendung in kosmetischen und pharmazeutischen zusammensetzungen
ES8604150A1 (es) Un procedimiento para la preparacion de medicamentos a base de derivados de la 1,4-dihidropiridina
AU1495695A (en) Use of aromatic steroids substituted in position 3 by a disubstituted aminoalkyloxy chain in order to obtain a medicament intended to control fertility and in particular male fertility, and the pharmaceutical compositions containing them
HU9400851D0 (en) Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines
ES8603175A1 (es) Procedimiento para preparar derivados de benzotiazol
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
HUT55391A (en) Process for producing aroyl-urea derivatives and pharmaceutical compositions containing them as active components
IL119054A (en) Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
HUT56549A (en) Process for producing new imidazole derivatives and pharmaceutical compositions comprising such imidazole derivatives as active ingredient
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
ES464729A1 (es) Un procedimiento para la preparacion de benzisotiazolonas amino-alquil sustituidas.
GR3021765T3 (en) Aminoalkylchomones, process for their preparation and pharmaceutical compositions containing them.
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
HUT60742A (en) Method for producing imidqzo-benzodiazepine-2-(1h)-one derivatives and pharmaceutical preparatives containing them